MENU
FOLD
AS OF
Jan 14, 04:59 PM (EDT)
Price
$14.37
Change
+$0.04 (+0.28%)
Capitalization
4.44B
35 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
FOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amicus Therapeutics (FOLD) Ownership - Who owns Amicus Therapeutics?

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.44B
P/E Ratio
N/A
Total Cash
263.84M
Projected Growth
N/A
Total Debt
442.82M
Revenue
598.7M
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash/Share
0.85
Total Debt/Equity
46.37
Revenue/Share
1.95 USD as % of share price

Fundamentals

FOLD
Capitalization
4.44B
P/E Ratio
N/A
Risk (Beta)
0.63
Dividend Yield
N/A
Total Cash
264M
Total Cash/Share
0.85
Total Debt
443M
Total Debt/Equity
46.37
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.95%
Revenue
599M
ROE
N/A
Book Value
230M
P/B Ratio
19.27
Cash Flow
N/A
Earnings
-0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.02M
Current Ratio
2.99
Current Revenue Per Employee
338799.60
Dividends Per Share - Security
N/A
EBITDA
59.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.49
Revenue To Assets
-1.70
Shares Held By Institutions
5.77B
Shares Outstanding - Current
309M
Total Liabilities
638M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.562
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Earnings TradersEarnings Traders
Annualized Return+26%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
FOLD
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FOLD showed earnings on November 04, 2025. You can read more about the earnings report here.
View AI-Driven Trading for FOLD
A.I. Advisor
published General Information

General Information

a developer of orally active drugs to treat human genetic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Hulfish Street
Phone
+1 609 662-2000
Employees
517
Web
https://www.amicusrx.com